Stem Cell Therapy for Cardiovascular Disease-Progress Despite Economic Turmoil
Executive Summary
The Fifth International Conference on Cell Therapy for Cardiovascular Disease is one of the largest medical meetings focused solely on cell-based therapies for cardiac repair and regeneration. While the primary focus during this year's meeting was on cardiac repair, vascular restoration and construction, critical limb ischemia, and noncardiac applications were also presented. Despite a difficult investment environment, optimism remains high with some therapies undergoing approval assessment.
You may also be interested in...
The Future of the Stem Cell Market
The stem cell market is beginning to show signs of significant revenue growth ahead, a development fueled by research in a variety of disease categories, some of which has already produced accepted therapies. In February, about three dozen firms gathered at the 5th Annual Stem Cell Summit, where participants showcased their technology in the hopes of securing financing.
The Future of the Stem Cell Market
The stem cell market is beginning to show signs of significant revenue growth ahead, a development fueled by research in a variety of disease categories, some of which has already produced accepted therapies. In February, about three dozen firms gathered at the 5th Annual Stem Cell Summit, where participants showcased their technology in the hopes of securing financing.
Stem Cell Summit 2008: Moving from Process to Product
More than 40 companies revealed promising research and clinical results at the 2008 Stem Cell Summit in February. Perhaps most impressive was the number of stem cell therapies already in use or tantalizingly close to market launch.